News

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Gilead ...
TODAY i have some great news to share. Besides the fact that last week was the King's Birthday, something exciting was happening in the HIV ...
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the top low volatility healthcare stocks to buy now. In a report released on ...
BMO Capital opined on Monday that recent reports indicating Robert F. Kennedy Jr.'s plan to remove all members of the U.S.
Lenacapavir can prevent 100 percent of HIV infections after just two injections per year, but getting it to SA could be a ...
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV.
Gilead Sciences (GILD) faces stock pressure as changes to the U.S. Preventive Services Task Force could impact PrEP drug ...
The European Medicines Agency (EMA) has recommended approving a twice-yearly injectable medication designed to prevent HIV ...
Eli Lilly's appeal of a decision by the EMA's human medicines committee not to approve its Alzheimer's disease therapy ...
PICKS are stories from many sources, selected by our editors or recommended by our readers because they are important, ...